Global Cell Lysis Market

Global Cell Lysis Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at XX% through 2020 to 2026, reaching nearly US$ 4,160.6 Mn.


Global Cell Lysis Market Overview:


Cell Lysis refers to as disruption of the cell membrane by osmotic, viral, and enzymatic mechanisms which help to compromise the integrity of the cells. The technique is majorly incorporated to degrade or denature sensitive proteins and DNA often used in western and southern blotting for the analysis of lipids, proteins, and other biomolecules.


The cell fractionation market is expected to develop at a high CAGR due to the growing demand for down streaming processes and the high generation of biopharmaceuticals.The global Cell Lysis market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Cell Lysis report also provides trends by market segments, technology, and investment with a competitive landscape.



To know about the Research Methodology :- Request Free Sample Report


Global Cell Lysis Market Dynamics:





Increasing government research funding

Disrupted cells are used by researchers to study the morphology and function of organelles and to create new cell therapies and other cell-based treatments. Because of the value of cell-based science, several government agencies have increased their funding for the expansion of such studies. Many government agencies have offered financial assistance in the form of loans, funds, and grants.


Moreover, The Government of Canada invested about USD 7.0 million in stem cell research in Canada through the Stem Cell Network’s competitive research funding scheme in March 2020. In 2019, Canada’s Minister of Science and Sport announced $22.7 million in funding, in addition to $33.4 million in funding from provincial governments, to support 36 research projects through Genome Canada.


Pharmaceutical and biopharmaceutical industries are becoming more widely used

Pharmaceutical and Biopharmaceutical industry expansion will also open up new growth opportunities for the market, as retrieval and purification of biopharmaceuticals require cell lysis and disruption. Furthermore, the adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries is expected to propel market growth, as cell lysis is critical in the bioprocessing phase.


The growth of new microfluidics products has resulted from the increased demand for successful tumor dissociation machinery. Microfluidic systems aid in the successful dissociation of tumor tissue into single cells, improving cellular recoach in terms of quantity and purity.

Personalized medicine is becoming more prevalent.


Personalized medicine is one of the most recent developments in gene-related studies that provides custom-tailored therapies based on a patient’s individual needs, which has enormous implications in disease prevention, diagnosis, prognosis, and therapeutics. Developing novel methods for clinical procedures such as personalized therapies, where cell lysis plays a major role, requires protein or nucleic acid analysis.

Furthermore, market growth is expected to be aided by a rise in the prevalence of various illnesses and demand for new therapies.




High cost of equipment’s

Cell-based studies are linked to high maintenance and expensive instruments, which could stifle market development in developing areas. Cell-based research should be properly maintained because contamination could adversely affect the overall test or sample.


High maintenance and high equipment costs, such as ultrasound and homogenization, may thus be used as stumbling blocks to the growth of the cell lysis industry. Another factor limiting this market’s growth is issues with mechanical methods to implement at the microscale level, as well as regulatory enforcement.



Emerging markets are becoming increasingly attractive

Emerging markets like China, Brazil, Mexico, and India provide major opportunities for cell lysis companies. The rising prevalence of chronic diseases, developments in research infrastructure, and favorable legislation for cell-based research in developing countries are all contributing factors.


Global Cell Lysis Market Segment Analysis:


Based on Product, The consumables segment is projected to grow at the highest CAGR during the forecast period. Purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research are the major factors supporting the growth of this segment.


Enzymes dominated the cell lysis and disruption market, and they are expected to continue to expand at a faster rate in the coming years. An application for selective product release and regulated lysis are two factors that contribute to the estimated share because they provide biological specificity to the process.



Based on Cell Type, the Mammalian Cell segment accounted for the largest market share in 2020. Because of increased investments by businesses and governments in cell-based science, as well as the rising prevalence of diseases such as HIV/AIDS and cancer, mammalian cells are the most widely fractionated cell types. The majority of cell lysis/cell fractionation is done in research laboratories and institutes including the National Institutes of Health (NIH).


Based on Application, The protein purification and isolation segment are projected to the highest growth in the cell lysis market during the forecast period. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major factors supporting the growth of this segment.


Based on Technology, the reagent-based method segment dominated during the forecast period. Reagent-based approaches are gentle and suitable for laboratory samples because they do not destroy the biological activity of the final products. Because of the aforementioned characteristics, they are an excellent option for laboratory use, resulting in their market share dominance in 2019 and over the forecast period.


On the flip side, physical disturbance methods require costly and bulky equipment, their acceptance has slowed recently. Physical disruption strategies are difficult to repeat due to the variability in the apparatus, thus reducing their market penetration.



Based on End Users, the segment of research laboratories and institutes had the largest share of the cell lysis industry, in 2020. This is because several biotechnology institutes study molecular biology and bioprocessing methods, including cell lysis protocols.


The protocols for tumorigenicity testing and research resulted in high demand for biospecimen banking for cell disruption techniques. In the coming years, clinical drug development studies are expected to drive progress. One of the major driving factors for this market is the growing government funding for cell-based research.


Global Cell Lysis Market Regional Insights:


North America held the largest share of the cell lysis market in 2020. The rising stem cell and cancer research activities, the surging government funding, the developing biotechnology, and pharmaceutical industries, as well as the rise of the aging population, are responsible factors for North America’s large share.


With the rise in COVID-19, there was a rise in lab testing techniques, which was expected to accelerate the cell lysis market’s development. Furthermore, to help the scientists who were also found studying COVID-19 cellular response and developing vaccines, there is a huge demand for cell lysis systems and reagents. In addition, the growing prevalence and incidences of many diseases, as well as rising research and development expenditures in the North American region, are driving a need for advanced R&D in all areas of life sciences.


As a result, the ongoing expansion of healthcare facilities in the United States, as well as an increase in patient population, create further opportunities for clinical laboratories to expand, boosting the market growth.


In the cell lysis/cell fractionation market, Europe is likely to have substantial growth throughout the forecast period owing to the rising prevalence of diseases and the rising geriatric population.


In contrast, Asia Pacific is expected to develop at the fastest rate in the coming years, especially in India and China. Government support for vaccine development, increased funding for cell-based research, low manufacturing costs, and the rising emphasis of global market players on emerging Asian economies are all driving this market’s growth.



The objective of the report is to present a comprehensive analysis of the Global Cell Lysis Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.


PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.


The report also helps in understanding the Global Cell Lysis Market dynamics, structure by analyzing the market segments and project the Global Cell Lysis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cell Lysis Market make the report investor’s guide.


Global Cell Lysis Market Key Developments:


Northeastern University and Thermo Fisher Scientific will collaborate in 2020. To advance analytical capabilities and drive research in precision medicine, monoclonal antibodies, and gene and cell therapies across the biopharmaceutical industry.


Danaher Corporation bought the biopharma business from GE Company’s life science division in 2020.


SPX FLOW introduced two new APV Rannie and Gaulin homogenizer models in April 2020 to improve efficiency.


The RNA lysis buffer reagent was introduced by Aalto Bio Reagents Ltd. in May 2020 for the pre-treatment of COVID 19 samples before testing. Due to the lack of similar reagents from other manufacturers in Europe, Aalto Bio developed this important RNA Lysis buffer.

For more information [email protected]

Global Cell Lysis Market Scope: Inquire before buying



Global Cell Lysis Market, by Region


  • North America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
  • South America


Global Cell Lysis Market Key Players


  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • F. Hoffman-La Roche Ltd.
  • Cell Signalling Technology
  • Miltenyi Biotec
  • Becton Dickinson & Company
  • Danaher Corporation
  • Bio-Rad Laboratories
  • BioVision, Inc.
  • Covaris, Inc.
  • Parr Instrument Company
  • Claremont Biosolutions
  • Others

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage


Email: [email protected]

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908


Author: Web Spangle

Leave a Reply

Your email address will not be published.